RT Journal Article
SR Electronic
T1 COVID-19 pandemics modeling with SEIR(+CAQH), social distancing, and age stratification. The effect of vertical confinement and release in Brazil
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.09.20060053
DO 10.1101/2020.04.09.20060053
A1 Lyra, Wladimir
A1 Nascimento, José-Dias do
A1 Belkhiria, Jaber
A1 de Almeida, Leandro
A1 Chrispim, Pedro Paulo M.
A1 de Andrade, Ion
YR 2020
UL http://medrxiv.org/content/early/2020/04/14/2020.04.09.20060053.abstract
AB As the COVID-19 epidemic rages, the total number of cases and deaths is raising across the world. This is certainly a challenging situation particularly for countries in a perilous socio-economic situation. With the rapid evolution of the disease, once introduced, making decisions becomes challenging particularly when past experience or data are not so relevant. This is when mathematical models could come handy to predict the evaluations of the epidemic. We designed a modified SEIR-type mathematical model which we assessed with up-to-date data of COVID-19 cases and deaths around the world, and in which the rate of transmission is derived from the observed delayed fatality rate. We used Brazil as an example for middle income countries and applied our model to the Brazilian context. We implement age stratification and a horizontal confinement followed by a “vertical confinement” exit strategy.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was receivedAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe code developed for the present work is public and made available at https://github.com/wlyra/covid19